Aspirin (rectal): Difference between revisions
No edit summary |
m (Bot: Adding CME Category::Cardiology) |
||
(8 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
|authorTag={{Ammu}} | |authorTag={{Ammu}} | ||
|OTC=Yes | |OTC=Yes | ||
|genericName=Aspirin suppository | |genericName=Aspirin suppository | ||
|aOrAn=an | |aOrAn=an | ||
|drugClass=[[analgesic]] | |drugClass=[[analgesic]] | ||
|indicationType=treatment | |indicationType=treatment | ||
|indication=minor aches, pains and headache and for reduction of fever | |indication=minor aches, pains and headache and for reduction of fever | ||
|adverseReactions=[[hypoprothrombinemia]], [[thrombocytopenia]], [[hypersensitivity]], [[cholestatic hepatitis]], [[tinnitus]] | |adverseReactions=[[hypoprothrombinemia]], [[thrombocytopenia]], [[hypersensitivity]], [[cholestatic]] [[hepatitis]], and [[tinnitus]] | ||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
<!--Adult Indications and Dosage--> | <!--Adult Indications and Dosage--> | ||
Line 20: | Line 18: | ||
=====Dosage===== | =====Dosage===== | ||
Remove suppository from plastic packet and insert into the rectum as far as possible. Adult: One suppository every 4 hours for no more than 10 days or as directed by a physician. Children under 12 years of age: Consult a physician. | Remove suppository from plastic packet and insert into the rectum as far as possible. Adult: One suppository every 4 hours for no more than 10 days or as directed by a physician. Children under 12 years of age: Consult a physician. | ||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
|offLabelAdultGuideSupport= | |||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Non–Guideline-Supported Use (Adult)--> | <!--Non–Guideline-Supported Use (Adult)--> | ||
|offLabelAdultNoGuideSupport= | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Pediatric Indications and Dosage--> | <!--Pediatric Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | <!--FDA-Labeled Indications and Dosage (Pediatric)--> | ||
|fdaLIADPed= | |fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Off-Label Use and Dosage (Pediatric)--> | <!--Off-Label Use and Dosage (Pediatric)--> | ||
<!--Guideline-Supported Use (Pediatric)--> | <!--Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedGuideSupport= | |offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Non–Guideline-Supported Use (Pediatric)--> | <!--Non–Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedNoGuideSupport= | |offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Contraindications--> | <!--Contraindications--> | ||
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | ||
|postmarketing=[[Hypoprothrombinemia]], [[thrombocytopenia]], [[hypersensitivity]], [[cholestatic hepatitis]], [[tinnitus]] | |postmarketing=[[Hypoprothrombinemia]], [[thrombocytopenia]], [[hypersensitivity]], [[cholestatic hepatitis]], [[tinnitus]] | ||
|drugInteractions=* Drug | |drugInteractions=* Drug | ||
Line 74: | Line 61: | ||
|administration=* Rectal | |administration=* Rectal | ||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | ||
<!--IV Compatibility--> | <!--IV Compatibility--> | ||
Line 81: | Line 66: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|drugBox=<!-- | |drugBox={{Drugbox2 | ||
| | | Watchedfields = changed | ||
| verifiedrevid = 464364671 | |||
| IUPAC_name = 2-(acetoxy)benzoic acid <!-- per ChemSpider --> | |||
| OtherNames = Acetylsalicylic acid | |||
| image = Aspirin-skeletal.svg | |||
| image2 = Aspirin-B-3D-balls.png | |||
<!-- | <!--Clinical data--> | ||
| | | Drugs.com = {{drugs.com|monograph|aspirin}} | ||
| MedlinePlus = a682878 | |||
| pregnancy_AU = C | |||
| pregnancy_US = C | |||
| pregnancy_US_comment= D in the 3rd trimester | |||
| legal_AU = S2 | |||
| legal_AU_comment = except when given intravenously (in which case it is schedule 4), used in animal medicine (schedule 5/6) or when the dose is higher than usual. | |||
| legal_UK = GSL | |||
| legal_US = OTC | |||
| routes_of_administration = Most commonly oral, also rectal, [[lysine acetylsalicylate]] may be given [[intravenous therapy|intravenously]] or [[intramuscular injection|intramuscularly]] | |||
<!--Pharmacokinetic data--> | |||
| bioavailability = 80–100%<ref name = MSR>{{cite web|title=Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more|work=Medscape Reference|publisher=WebMD|accessdate=3 April 2014|url=http://reference.medscape.com/drug/zorprin-bayer-buffered-aspirin-343279#showall}}</ref> | |||
| protein_bound = 80–90%<ref name = MD>{{cite web|title=Aspirin|work=Martindale: The Complete Drug Reference|publisher=Pharmaceutical Press|date=14 January 2014|accessdate=3 April 2014|url=http://www.medicinescomplete.com/mc/martindale/current/2601-s.htm|editor=Brayfield, A}}</ref> | |||
| metabolism = [[Liver|Hepatic]], ([[CYP2C19]] and possibly [[CYP3A]]), some is also hydrolysed to salicylate in the gut wall.<ref name = MD/> | |||
| elimination_half-life = Dose-dependent; 2–3 hours for low doses, 15–30 hours for large doses.<ref name = MD/> | |||
| excretion = Urine (80–100%), sweat, saliva, feces<ref name = MSR/> | |||
<!--Pharmacodynamics--> | <!--Identifiers--> | ||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 50-78-2 | |||
| ATC_prefix = A01 | |||
| ATC_suffix = AD05 | |||
| ATC_supplemental = {{ATC|B01|AC06}}, {{ATC|N02|BA01}} | |||
| PubChem = 2244 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB00945 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 2157 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = R16CO5Y76E | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D00109 | |||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 15365 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 25 | |||
| PDB_ligand = AIN | |||
<!--Chemical data--> | |||
| C=9 | H=8 | O=4 | |||
| molecular_weight = 180.157 g/mol | |||
| smiles = O=C(Oc1ccccc1C(=O)O)C | |||
| InChI = 1/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = BSYNRYMUTXBXSQ-UHFFFAOYSA-N | |||
| synonyms = 2-acetoxybenzoic acid<br />acetylsalicylate<br />acetylsalicylic acid<br />O-acetylsalicylic acid | |||
| density = 1.40 | |||
| melting_point = 136 | |||
| boiling_point = 140 | |||
| boiling_notes = (decomposes) | |||
| solubility = 3 | |||
}} | |||
|mechAction=<!--Structure--> | |||
|structure=<!--Pharmacodynamics--> | |||
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label. | |PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label. | ||
Line 102: | Line 143: | ||
<!--How Supplied--> | <!--How Supplied--> | ||
|howSupplied=* Suppositories sealed in imprinted plastic packet. | |howSupplied=* Suppositories sealed in imprinted plastic packet. | ||
|storage=* Do not use if imprinted packet is opened or damaged. Store in a cool place 8˚- 15˚C (46˚- 59˚F) or refrigerate. | |storage=* Do not use if imprinted packet is opened or damaged. Store in a cool place 8˚- 15˚C (46˚- 59˚F) or refrigerate. | ||
|packLabel= | |packLabel=[[File:Aspirin rectal.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.]] | ||
[[File:Aspirin R 2.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.]] | |||
[[File:Aspirin R3.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.]] | |||
[[File:Aspirin R4.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.]] | |||
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label. | |fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label. | ||
Line 112: | Line 156: | ||
<!--Brand Names--> | <!--Brand Names--> | ||
|brandNames=* ASPIRIN®<ref>{{Cite web | title = ASPIRIN- aspirin suppository | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cce244aa-cd79-49c8-b68e-267f2bd0ef67}}</ref> | |brandNames=* ASPIRIN®<ref>{{Cite web | title = ASPIRIN- aspirin suppository | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cce244aa-cd79-49c8-b68e-267f2bd0ef67}}</ref> | ||
}} | }} | ||
<!--Label Display Image--> | <!--Label Display Image--> | ||
<!--Category--> | <!--Category--> | ||
[[CME Category::Cardiology]] | |||
[[Category:Drug]] | [[Category:Drug]] | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | |||
[[Category:Cardiology]] | |||
[[Category:Acetates]] | |||
[[Category:Benzoic acids]] | |||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Antiplatelet drugs]] |
Latest revision as of 00:37, 15 March 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Aspirin (rectal) is an analgesic that is FDA approved for the treatment of minor aches, pains and headache and for reduction of fever. Common adverse reactions include hypoprothrombinemia, thrombocytopenia, hypersensitivity, cholestatic hepatitis, and tinnitus.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indication
- For the relief of minor aches, pains and headache and for reduction of fever.
Dosage
Remove suppository from plastic packet and insert into the rectum as far as possible. Adult: One suppository every 4 hours for no more than 10 days or as directed by a physician. Children under 12 years of age: Consult a physician.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (rectal) in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (rectal) in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Aspirin (rectal) in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (rectal) in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (rectal) in pediatric patients.
Contraindications
There is limited information regarding Aspirin (rectal) Contraindications in the drug label.
Warnings
There is limited information regarding Aspirin (rectal) Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Aspirin (rectal) in the drug label.
Postmarketing Experience
Hypoprothrombinemia, thrombocytopenia, hypersensitivity, cholestatic hepatitis, tinnitus
Drug Interactions
- Drug
- Description
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Aspirin (rectal) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Aspirin (rectal) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Aspirin (rectal) with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Aspirin (rectal) with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Aspirin (rectal) with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Aspirin (rectal) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Aspirin (rectal) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Aspirin (rectal) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Aspirin (rectal) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Aspirin (rectal) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Aspirin (rectal) in patients who are immunocompromised.
Administration and Monitoring
Administration
- Rectal
Monitoring
There is limited information regarding Monitoring of Aspirin (rectal) in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Aspirin (rectal) in the drug label.
Overdosage
There is limited information regarding Aspirin (rectal) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
Mechanism of Action
There is limited information regarding Aspirin (rectal) Mechanism of Action in the drug label.
Structure
There is limited information regarding Aspirin (rectal) Structure in the drug label.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Aspirin (rectal) in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Aspirin (rectal) in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Aspirin (rectal) in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Aspirin (rectal) in the drug label.
How Supplied
- Suppositories sealed in imprinted plastic packet.
Storage
- Do not use if imprinted packet is opened or damaged. Store in a cool place 8˚- 15˚C (46˚- 59˚F) or refrigerate.
Images
Drug Images
{{#ask: Page Name::Aspirin (rectal) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Aspirin (rectal) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Aspirin (rectal) in the drug label.
Precautions with Alcohol
- Alcohol-Aspirin (rectal) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ASPIRIN®[3]
Look-Alike Drug Names
There is limited information regarding Aspirin (rectal) Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ 1.0 1.1 "Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 3 April 2014.
- ↑ 2.0 2.1 2.2 Brayfield, A, ed. (14 January 2014). "Aspirin". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 3 April 2014.
- ↑ "ASPIRIN- aspirin suppository".